Attention-Deficit/Hyperactivity Disorder (ADHD) is a childhood psychiatric disorder often comorbid with disruptive behavior disorders (DBDs). ADHD comorbid with DBDs (ADHD+DBDs) is a complex phenotype with a risk component that can be attributed to common genetic variants. Here we report a large GWAS meta-analysis of ADHD+DBDs based on seven cohorts in total including 3,802 cases and 31,305 controls. Three genome-wide significant loci were identified on chromosomes 1, 7, and 11. A GWAS meta-analysis including a Chinese cohort supported the locus on chromosome 11 to be a strong risk locus for ADHD+DBDs across European and Chinese ancestries (rs7118422, P=3.15x10 -10 , OR=1.17). This locus was not associated with ADHD without DBDs in a secondary GWAS of 13,583 ADHD cases and 22,314 controls, suggesting that the locus is a specific risk locus for the comorbid phenotype.
Introduction
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common childhood behavioral disorder affecting around 5% of children and 2.5% of adults 1 . Comorbidity with other psychiatric disorders is common among children, and disruptive behavior disorders (DBDs) are the most frequently occurring conditions 2 . DBDs comprise oppositional defiant disorder and conduct disorder. Both have a childhood onset and are characterized by persistent patterns of antisocial rule-breaking and aggressive behaviours like being destructive, physically cruel towards others, and rule violations 3 . DBDs have a prevalence of 3-10% percent 4,5 among children and, are around twice as frequent in males compared to females 6 . Different comorbidity rates of ADHD with DBDs have been reported, some studies have found that around 30% of children with ADHD have comorbid DBDs (ADHD+DBDs) 6, 7 , while a study of 1.92 million individuals from Denmark, found that 17% of those with ADHD were also diagnosed with DBDs 8 . Among those with DBDs in the same Danish cohort, more than half (57%) also had a comorbid diagnosis of ADHD 8 . ADHD in combination with diagnosed DBDs or excessive aggressive and disruptive behaviors increases the risk for several detrimental outcomes including increased risks for substance use disorders 9,10 , transgression 11, 12 , risky behavior 13 , and premature death compared to those only diagnosed with ADHD 8, 13 .
Both genetic and environmental factors influence the risk for ADHD as well as DBDs with twin heritability estimates of 0.74 14 and 0.40-0.70 [15] [16] [17] , respectively. Twin studies have also suggested that ADHD+DBDs is a more severe and genetically loaded subtype of ADHD than ADHD without comorbid DBDs 18 . Siblings of individuals with ADHD+DBDs have a higher recurrence risk to develop ADHD+DBDs compared to siblings of individuals having ADHD without DBDs 19, 20 . Individuals with ADHD+DBDs also have an increased polygenic burden of common ADHD risk variants compared to individuals with only ADHD, further supporting the hypothesis that ADHD+DBDs reflect a higher load of genetic risk 21 . However, it seems unlikely that ADHD risk variants alone can fully account for the underlying genetic risk that mediates aggressive and disruptive behaviours in individuals with ADHD+DBDs. Family studies have found that ADHD and DBDs have distinct genetic architectures with moderate to high genetic overlap in the range of 0.34 -0.74 22, 23, 24 . The existence of genetic risk factors specific to the aggressive and disruptive component of ADHD+DBDs finds support from a twin study where DBDs had an estimated heritability of 0.33-0.64 after controlling for ADHD, with a significant genetic component also observed for DBDs in individuals without ADHD 25 .
Several genome-wide association studies (GWASs) have focused on diagnosed DBDs 26, 27 or aggressive and anti-social behaviors 28, 29 , with only limited success in identifying genome-wide significant loci and no conclusive, replicated findings 26, 28, 29 . Only two genome-wide studies have focused specifically on ADHD+DBDs. One small genome-wide linkage study examined DBDs in individuals suffering from ADHD 30 and another, while not assessing DBD diagnoses, examined the aggressive component in individuals with ADHD 31 . Neither study reported genome-wide significant loci.
In the current study we performed the largest GWAS-meta analysis of ADHD+DBDs to date using a Danish nation-wide cohort from iPSYCH and samples from the Psychiatric Genomics Consortium (PGC). We report the first three genome-wide significant loci for ADHD+DBDs, located on chromosome 1, 7, and 11, and show generalization to a Chinese cohort for the locus on chromosome 11. Characterizing the polygenic architecture of ADHD+DBDs revealed a high genetic overlap with childhood aggression in the general population and anti-social behavior, considerably higher than found for ADHD without DBDs.
Results

GWAS meta-analysis and generalization across European and Chinese ethnicities
The meta-analysis included data from the Danish iPSYCH cohort (2, 155 Figure 1A and Supplementary Figure 1 
Homogeneity of effects in the PGC and iPSYCH cohorts and intercept evaluation
To evaluate the consistency of the genetic architecture underlying ADHD+DBDs in iPSYCH and the PGC cohorts, we estimated the genetic correlation between the two using LD score regression 32, 33 . The genetic correlation between the PGC cohorts and the iPSYCH cohort was high (r g =0.934, SE=0.14, P=3.26x10 -11 ) supporting consistency of the phenotypes analyzed in the cohorts. In addition, no variants demonstrated significant heterogeneity among studies ( Supplementary Figure 3 LD Score regression analysis indicated that the observed deviation of the genome-wide test statistics from the null distribution (lambda=1.11, Figure 1B ) was mainly caused by 6 polygenicity. The intercept ratio estimate suggests that the majority of the inflation of the mean ߯ ଶ statistic of the GWAS meta-analysis is attributable to polygenic effects (ratio=0.87, SE=0.0662) rather than confounding factors. The estimated remaining contribution of confounding factors was small and non-significant (intercept =1.015; SE=0.008; P=0.064).
Trans-ancetry GWAS meta-analysis
To replicate and generalize the findings to other ethnicities, a GWAS of ADHD+DBDs was performed in a Chinese cohort (406 cases, 917 controls) and a and fixed effects meta-analysis including the Chinese, European iPSYCH and PGC cohorts was evaluated (total 4,208 cases and 32,222 controls) was performed. The three loci identified in the main analysis were evaluated for significance in the trans-ancestry GWAS meta-analysis. The locus on chromosome 11 was nominally significant in the Chinese cohort (P=0.006), and the association P-value in the metaanalysis became stronger in the trans-ancestry GWAS meta-analysis (P=3.15x10 -10 , OR=1.17) ( Figure 2 and Supplementary Figure 5 ) suggesting the chromosome 11 locus to be a risk locus for ADHD+DBDs across ethnicities. The results incorporating the Chinese cohort did not support replication of the other two loci ( Table 1) .
Secondary GWASs
For subsequent evaluation of how much of the signal in the GWAS meta-analysis of ADHD+DBDs was driven by the aggressive component of the comorbid phenotype, two additional GWASs were conducted using iPSYCH samples. To adjust for the effect of ADHD, we performed a case-only GWAS comparing 1,959 individuals with ADHD+DBDs against 13,539 individuals having ADHD without DBDs, referred to as the "ADHD+DBD vs. ADHD-only GWAS". Additionally, a GWAS of 13,583 cases having ADHD without DBDs and 22,314 population-based controls, referred to as the "ADHD without DBDs GWAS", was performed (the case-control numbers differ between GWASs due to deviation in removal of related individuals and genetic outliers). ADHD-only GWAS was significantly larger than the proportion in the ADHD without DBDs GWAS (P = 7.679x10 -16 ), which suggests that the associations in the GWAS meta-analysis of ADHD+DBDs reflects association with the comorbid phenotype beyond association with risk for ADHD alone.
Of the significant loci from the GWAS of ADHD+DBDs, the loci on chromosomes 7 and 11 had nominally stronger effect sizes in the ADHD+DBD vs. ADHD-only GWAS compared to the ADHD without DBDs GWAS, while the chromosome 1 locus had similar effects in both secondary GWASs (Supplementary Table 9 ). The difference is most striking for rs7118422 on chromosome 11, which showed minimal evidence for association with ADHD without DBDs (OR=1.022, p=0.175) versus more strongly suggestive evidence of association with ADHD+DBD vs. ADHD-only (OR=1.126, p=7.07 x10 -04 ). To help formalize this comparison, we used mtCOJO 34 to estimate the joint effects of the significant loci from the GWAS of ADHD+DBDs conditional on effects mediated through the genetics of ADHD without DBDs.
Under this model (see Methods) none of the three loci reached genome-wide significance for a direct effect on ADHD+DBDs, although the locus on chromosome 11 retained the most robust signal after correction for ADHD without DBDs (OR adjusted =1.14; P adjusted =1.43x10 -06 ).
Gene-based association test
A gene-based association analysis was performed using MAGMA 35 . Six genes (RRM1, STIM1, MAML3, ST3GAL3, KDM4A and PTPRF) were significantly associated with ADHD+DBDs (P < 2.7x10 -6 ; correcting for 18,553 genes analyzed; Supplementary Figure 6 and Supplementary   Table 4 ). Three genes (ST3GAL3, KDM4A and PTPRF) are located in the genome-wide significant locus on chromosome 1, and two genes (RRM1, STIM1) in the genome-wide significant locus on chromosome 11. One gene (MAML3) was located on chromosome 4 and had not been identified as a risk locus in the single variant analysis.
To evaluate if the gene-based association signals reflected the aggressive and disruptive component of the ADHD+DBDs phenotype rather than ADHD alone, we did a gene-set test of the most associated genes from the ADHD+DBDs GWAS meta-analysis (P<10 -3 , 80 genes) using the results from the two secondary GWASs. The gene-set was significantly associated with ADHD without DBDs (P=9x10 -4 ), but had a much stronger association in the ADHD+DBD vs.
ADHD only GWAS (P = 9.28x10 -32 ).
Association of genetically regulated gene expression with ADHD+DBDs
Association of genetically regulated gene expression with ADHD+DBDs was analyzed in 12 brain tissues from GTEx 36 (version 6p) using MetaXcan 37 . Depending on the tissue, 2,042-6,094 genes were tested (Supplementary Table 4 ). Three genes were differently expressed in ADHD+DBDs cases compared with controls after Bonferroni correction (correcting for the total number of tests performed (43, 142) ; P<1,16x10 -6 ); RRM1 (chromosome 11) was lower expressed in cases, and RAB3C (chromosome 5) and LEPRE1 (chromosome 1) showed a higher expression in cases when compared to controls (Supplementary Table 4 ). The genes on chromosome 1 and 11 were located in or near genome-wide significant loci, whereas the locus on chromosome 5 was novel.
SNP heritability
The estimated h 2 SNP for ADHD+DBDs was 0.25 using LD score regression 32 with a prevalence estimate of 2% in the population ( Supplementary Table 6 ). When considering only the iPSYCH cohort, a higher SNP heritability was found for ADHD+DBDs (h 2 SNP =0.34; SE=0,05) compared with the GWAS of ADHD without DBDs (h 2 SNP =0.20; SE=0.02). This pattern remained similar when using GCTA and was stable when assuming a lower prevalence of ADHD+DBDs and higher prevalence of ADHD without DBDs ( Supplementary Table 6 ). Additionally, common variants explained a small fraction of the variation in the ADHD+DBDs phenotype compared with the ADHD without DBDs phenotype (h 2 SNP =0.08; SE=0.04, GCTA estimate) (Supplementary Table 6 ).
Genetic correlation with aggression related phenotypes
We estimated the genetic correlations of ADHD+DBDs with aggression related phenotypes and GWAS results from analyses of aggressive behaviors in 18,988 children 28 (EAGLE aggression) and antisocial behavior in 16,400 individuals 29 (Broad Antisocial Behaviour Consortium (BroadABC)) using LD score regression. We found a strong genetic correlation of ADHD+DBDs with aggression in children (EAGLE aggression, r g =0.81, P=0.001) and antisocial behavior (BroadABC, r g =0.82, P=0.007) (Supplementary Table 7 ). In contrast, ADHD without DBDs was only significantly correlated with aggression in children (r g =0.74, P=5e-5).
Analyzing only the iPSYCH cohort, ADHD+DBDs demonstrated a nominally higher positive genetic correlation than ADHD without DBDs with aggression in children (ADHD+DBDs vs EAGLE aggression, r g =0.85, P=5x10 -4 ; ADHD without DBDs vs EAGLE aggression r g =0.74, P=4.58x10 -5 ) and anti-social behavior (ADHD+DBDs vs BroadABC, r g = 0.92, P=9x10 -3 ; ADHD without DBDs vs BroadABC, r g =0.56, P=0.01). The differences in the r g s, however, were not statistically significant when assessed using the jackknife method.
ADHD+DBD vs. ADHD-only polygenic risk score analysis
Case-only polygenic risk score (PRS) analyses were done to evaluate if ADHD+DBDs cases are enriched for variants associated with 22 relevant phenotypes compared with cases having ADHD without DBDs. Investigating PRS from phenotypes related to personality, cognition, and psychiatric disorders, seven phenotypes were significantly associated with ADHD+DBDs compared with ADHD without DBDs after multiple testing correction ( Supplementary Table 8 ).
Significantly increased PRS for aggressive behavior 28 
Discussion
This study is the first to identify genome-wide significant loci for ADHD+DBDs based on a meta-analysis of 3,802 cases and 31,305 controls from the iPSYCH cohort and six cohorts from PGC. We identified three risk loci on chromosomes 1, 7, and 11 with odds ratios ranging from Table 9 ).; consistent with this, evidence for a direct effect of the locus on ADHD+DBDs remained after adjusting for the effect of ADHD alone in the mtCOJO analysis (Supplementary Table 3 ).
In contrast, the locus on chromosome 1, which had been identified as a strong risk locus for ADHD previously 41 , seems to reflect an association with ADHD. This locus remained genomewide significant in the GWAS of ADHD without DBDs ( Supplementary Table 9 ) and the association with ADHD+DBDs decreased considerably in the analyses adjusting for the effect of ADHD without DBDs and in the ADHD+DBD vs. ADHD-only GWAS ( Supplementary Table 3 and 9).
The locus on chromosome 7, seems to be a shared risk locus between ADHD+DBDs and ADHD without DBDs. The locus remained moderately associated in the GWASs adjusted for ADHD (Supplementary Table 3 and 9) as well as in the ADHD without DBDs GWAS (Supplementary Table 9 ). The locus is located in MAD1L1, which is involved in mitotic spindle-assembly checking before anaphase. The locus is novel with respect to ADHD and DBDs, but was found genome-wide significantly associated with schizophrenia and bipolar disorder 42, 43, 44 (however involving LD distinct variants) suggesting that MAD1L1 could be a cross-disorder risk gene for several psychiatric disorders.
The locus most strongly associated with ADHD+DBDs on chromosome 11 is located in STIM1
(Supplementary Figure 1C ), a gene not previously implicated in ADHD, DBDs, aggressionrelated phenotypes, or psychiatric disorders. STIM1 encodes a transmembrane protein (STIM1)
in the endoplasmatic reticulum (ER) that acts as a sensor of calcium. Upon calcium depletion from the ER, STIM1 is responsible for an influx of calcium ions from the extracellular space through store-operated calcium channels to refill ER stores [45] [46] [47] . Store-operated calcium entry may also be involved in neuronal calcium signaling 48 , and recent evidence indicates that STIM1 plays a role in synaptic plasticity affecting learning and memory 48, 49 . These results are interesting in the light of the observed learning deficits associated with aggressive behaviors and accumulating evidence that suggests calcium signaling to be involved in several psychiatric disorders [50] [51] [52] . Alternatively, analysis of genetically regulated gene expression suggested that the variants in the genome-wide significant locus might affect expression of RRM1, with a decreased RRM1 expression being associated with ADHD+DBDs. RRM1 is oriented in a tail-to-head configuration with STIM1, which lie 1.6 kb apart, and is involved in biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides necessary for DNA replication. To our knowledge, this gene has not previously been associated with psychiatric disorders.
Six genes were exome-wide significantly associated with ADHD+DBDs, including two implicated by variants in or near the genome-wide significant locus on chromosome 11 (RRM1 and STIM1) and with three (ST3GAL3, KDM4A, and PTPRF) out of the remaining four located in or near the genome-wide significant locus on chromosome 1. The top-associated genes (80 genes) seem to mainly to reflect association with the aggressive and disruptive component of the ADHD+DBDs phenotype, since they were more strongly associated in the ADHD+DBD vs.
ADHD-only GWAS (where the effect of ADHD is corrected out) than in the ADHD without DBDs GWAS. Likewise, the most strongly associated single markers (with P< 1x10 -4 ) in the GWAS meta-analysis of ADHD+DBDs showed higher consistency in the direction of association in the ADHD+DBD vs. ADHD-only GWAS than in the GWAS of ADHD without Table 8 ). The significantly higher burden of ADHD risk variants among individuals with ADHD+DBDs was especially evident when examining individuals belonging to the 20% of ADHD cases with the highest ADHD genetic risk load, who had an odds ratio of 2.48
for having comorbid DBDs (Supplementary Figure 7A) . This is also a replication of previous findings of a higher load of ADHD risk variants in individuals with ADHD and comorbid conduct disorder compared to those having only ADHD 21 .
Going beyond ADHD risk burden, the common variant component of DBDs could also include variants distinctly associated with aggression. This idea is supported by our finding of increased PRS for aggression in ADHD+DBDs compared to ADHD without DBDs (Supplementary Figure   7B ). This conclusion is reinforced by the genetic correlation results, where we found somewhat higher genetic correlation of ADHD+DBDs with both aggressive behavior in children 28 and antisocial behavior 29 ( Supplementary Table 7 ) compared to those found for ADHD without DBDs.
Additionally, these results imply that the genetic architecture underlying the aggressive and Aggressive behavior is stable across age intervals during childhood 55 , and twin studies have suggested genetics to play an important role in this stability 55, 56 . Moreover, early aggression might be predictive of later serious anti-social behaviour 57 resulting in increased risk of getting a diagnosis of antisocial personality disorder 58 . Our results suggest that common genetic variants play an important role in childhood aggression, which has also been reported previously 28 , and that the subsequent risk for anti-social behavior in individuals with ADHD+DBDs has an underlying biological cause involving common variants.
We identified individuals with ADHD+DBDs to have increased load of variants associated with worse cognition compared to individuals having ADHD without DBDs ( Supplementary Table 8 ;
Supplementary Figure 7C -F). This could reflect the increased genetic load of ADHD risk variants in ADHD+DBDs, since ADHD has a strong negative genetic correlation with cognitionrelated phenotypes 41 . However, it might also involve variants associated with anti-social behavior, which also has a negative genetic correlation with educational performance 29 . This latter idea is supported by epidemiological studies linking aggression to decreased educational attainment [59] [60] [61] . Finally, we found a significantly higher load of variants associated with younger age at birth of first child in ADHD+DBDs compared to ADHD without DBDs, in line with the observed positive genetic correlations of ADHD and anti-social behavior with having children earlier 29, 41 and with evolutionary theories suggesting that aggression has played a role when competing for access to mates 62 .
In summary, we identified three genome-wide significant loci for ADHD+DBDs. The locus on chromosome 11 was associated most strongly with the comorbid phenotype, and seems to be a cross ancestry risk locus in European and Chinese. Our results suggest that the aggressive and disruptive behavioral component of the ADHD+DBDs phenotype has a biological cause, which in part can be explained by common risk variants associated with ADHD, aggressive and antisocial behavior. Individuals with ADHD+DBDs therefore represent a more severe phenotype with respect to the genetic risk load than ADHD without DBDs, most likely including loci which are distinct to ADHD+DBDs. This study represents the first step towards a better understanding of the biological mechanism underlying ADHD+DBDs.
Methods
Samples -the iPSYCH cohort
The iPSYCH cohort is a population-based nation-wide cohort which include 79,492 genotyped individuals (∼50,000 diagnosed with major psychiatric disorders and ∼30,000 controls). The cohort was selected, based on register information from a baseline birth cohort of all singletons dried blood spot samples and whole genome amplified in triplicates as described previously 64, 65 .
Genotyping and calling of genotypes were performed as described in 63, 66 .
For this study cases and controls were identified based on diagnoses given in 2016 or earlier in the Danish Psychiatric Central Research Register register 67 
Samples -cohorts from the Psychiatric Genomics Consortium
For the meta-analysis, seven ADHD cohorts (six cohorts of European ancestry and one of Chinese ancestry) aggregated by PGC with information about diagnoses of ADHD+DBDs were
included. An overview of the cohorts including genotyping information and diagnosis criteria can be found in Supplementary Table 2 . Detailed descriptions of the cohorts can be found elsewhere 66 . Details on approval authorities can be found in Supplementary Table 2 . Relatedness and population stratification were evaluated using a set of high quality genotyped markers (minor allele frequency (maf) >0.05, HWE P >1x10 -4 and SNP call rate >0.98) pruned for linkage disequilibrium (LD) resulting in ~30,000 pruned variants (variants located in longrange LD regions defined by Price et al. 73 were excluded). Genetic relatedness was estimated using PLINK v1.9 74, 75 to identify first and second-degree relatives (ߨ ො >0.2) and one individual was excluded from each related pair (cases preferred kept over controls). Genetic outliers were excluded based on principal component analyses (PCA) using EIGENSOFT 76, 77 . For iPSYCH a genetic homogenous sample was defined based on a subsample of individuals being Danes for three generations as described in Demontis and Walters et al. 66 . For the PGC samples genetic outliers were removed based on visual inspection of the first six PCs. For all cohorts PCA was redone after exclusion of genetic outliers.
Quality control and imputation
GWAS meta-analysis and generalization across European and Chinese ethnicities
Association analysis was done using additive logistic regression and the imputed marker dosages, covariates from principal component analyses after removal of genetic outliers and other relevant covariates (Supplementary Table 2 ). Meta-analysis of the iPSYCH cohort (2, 155 cases, 22,664 controls) and the six PGC cohorts (1,647 cases, 8,641 controls) was done using an inverse standard error weighted fixed effects model and the software METAL 78 and included in total 3,802 cases and 31,305 controls.
For generalization of genetic risk variants across European and Chinese ancestries, a GWAS meta-analysis was done as described above including the iPSYCH cohort, the six European PGC cohorts and the cohort of Chinese ancestry. In total, 4,208 cases and 32,222 controls were included. No individual genotypes were used for the meta-analysis.
Homogeneity of effects in the PGC and iPSYCH cohorts and intercept evaluation
LD score regression 32, 33 was used to estimate the genetic correlation using summary statistics from GWAS of ADHD+DBDs in the iPSYCH cohort and meta-analysis of the six European PGC cohorts. Only variants with an imputation info score > 0.9 were included. The intercept was restricted to one as there was no sample overlap and no indication of population stratification.
The ratio (ratio = (intercept-1)/(mean chi 2 − 1)) from LD score regression was used to evaluate the relative contribution of polygenic effects and confounding factors to the observed deviation from the null in the genome-wide distribution of the ߯ ଶ statistics of the GWAS meta-analysis of ADHD+DBDs.
Secondary GWASs
In order to correct out the effect of ADHD we did a case-only GWAS comparing 1,959 individuals with ADHD+DBDs against 13,539 individuals having ADHD without DBDs, referred to as the "ADHD+DBD vs. ADHD-only GWAS". Additionally, a GWAS of 13,583 cases having ADHD without DBDs and 22,314 population-based controls referred to as the "ADHD without DBDs GWAS" was performed. Both GWASs were based only on iPSYCH samples and performed using additive logistic regression and the imputed marker dosages, covariates from principal component analyses after removal of genetic outliers and covariates indicating the 23 genotyping waves.
The summary statistics from the two secondary GWASs were used to evaluate direction of association of the top loci associated with ADHD+DBDs using a sign test based on LD distinct variants (r 2 <0.2, 281 variants) with association P-values less than 1x10 -4 in the GWAS metaanalysis of ADHD+DBDs.
We also did an mtCOJO 34 analysis to estimate the effect of the top loci for ADHD+DBDs conditional on genetic effects on ADHD alone. This was done using summary statistics from the GWAS meta-analysis of ADHD+DBDs and from the GWAS of ADHD without DBDs. The analysis was run using mtCOJO 3 4 implemented in GCTA 79 using standard procedures. Following default settings, estimation of the effect of ADHD without DBDs on ADHD+DBDs (as part of the indirect path contributing to marginal ADHD+DBDs associations) was performed using variants that were genome-wide significant in the GWAS of ADHD without DBDs (P<5x10 -8 ) and not in linkage disequilibrium (r 2 < 0.05; 7 index variants). No variants were removed due to evidence of pleiotropy (HEIDI-outlier threshold of P=0.01).
Gene-based association test
Gene-based association analysis was done using MAGMA 1.05 35 and summary statistics from the GWAS meta-analysis. Variants were annotated to genes using the NCBI37.3 gene definitions and no window around genes was used. MAGMA summarize association signals observed for variants located in a gene into a single P-value while correcting for LD in a reference genome.
For this the European samples from the 1000 Genomes phase 3 were used.
The most associated genes in the GWAS meta-analysis of ADHD+DBDs (80 genes, P<10 -3 )
were evaluated in a gene-set test for association with ADHD+DBDs compared to ADHD without DBDs and for association with ADHD without DBDs. Gene-based P-values were generated using summary statistics from the two secondary GWASs (ADHD+DBDs vs ADHD-only GWAS and ADHD without DBDs GWAS) and subsequently gene-set tests were done using MAGMA 1.05 35 . MAGMA performs a competitive test to analyze if the gene set is more strongly associated with the phenotype than other genes, while correcting for a series of confounding effects such as gene length and size of the gene-set.
Association of the genetically regulated gene expression with ADHD+DBDs
Association of the genetically regulated gene expression with ADHD+DBDs was analyzed in 12 brain tissues from GTEx 36 (version 6p) using MetaXcan 37 . MetaXcan is an extension of PrediXcan 80 that can be used to test for differences in gene expression using summary statistics.
We used high-performance prediction models for MetaXcan based on variants located within 1
Mb +/-of transcription start site and trained using elastic net regression and 10-fold crossvalidation 4 downloaded from http://predictdb.org. MetaXcan also requires covariance matrices of the variants within each gene model for each tissue. Covariance matrices calculated from 503 individuals with European ancestry from the 1000 genomes project 81 available with the prediction models at http://predictdb.org were used.
SNP heritability
The SNP heritability (h 2 SNP ) was estimated using LD score regression 32 and the summary statistics from the GWAS meta-analysis of ADHD+DBDs. The heritability was estimated on the liability scale assuming a population prevalence of ADHD+DBDs of 2% and 1%.
In order to evaluate the extent to which common genetic variants contributes to the risk of ADHD+DBDs compared to having ADHD without DBDs, the SNP heritability of for the two phenotypes were estimated only in iPSYCH samples. This was done using LD score regression and univariate GREML analyses in GCTA 79 . h 2 SNP was estimated on the liability scale assuming a population prevalence of 2% and 1% for ADHD+DBDs and 3% and 4% for ADHD without DBDs. The GCTA analyses were corrected for the same covariates as used in the GWASs.
Additionally, we evaluated how much of the variance in the ADHD+DBDs phenotype could be explained by common genetic variation in the context of ADHD. For this we did a case-only approach including 1,959 cases with ADHD+DBDs and 13,539 individuals having ADHD without DBDs. This was only done using GCTA due to a low polygenic signal in the ADHD+DBD vs. ADHD-only GWAS GWAS (mean ߯ ଶ = 1.06).
Genetic correlation with aggression related phenotypes
The genetic overlap of ADHD+DBDs with aggression related phenotypes was evaluated by estimating genetic correlations using LD score regression 32 and the summary statistics from the GWAS meta-analysis of ADHD+DBDs and results from two aggression related GWASs. One is a GWAS meta-analysis of scores of aggressive behaviors in 18,988 children 28 
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